Lotus Eye Hospital and Institute Limited Share Price & Analysis

₹109.54−0.10%Updated 28 Oct 2026, 03:30 pm IST

LTP

₹109.54−0.10%

Open

₹111.00

High

₹111.00

Low

₹109.10

₹109.54

52W High

₹147.00

52W Low

₹67.72

Volume

Lot Size

Sector

Healthcare

Market Cap

₹225 Cr

Face Value

—

Small Cap

Price Chart

Candle

Range

Patterns

Fundamentals

P/E

2709.25

Sector P/E

50.20

P/B

3.45

EPS

₹0.04

ROE

—

ROCE

—

D/E Ratio

0.08

Div Yield

—

Book Value

₹31.41

Strengths

Virtually debt-free

Concerns

Premium to sector peers (P/E 2,709.3x vs industry 50.2x)

Peer Comparison

Company	CMP	Mkt Cap	P/E	P/B	ROE %	ROCE %	D/E
SUNPHARMA Sun Pharmaceutical Industries Limited	₹1,758	₹4.2L Cr	33.2	5.05	16	20.5	0.07
DIVISLAB Divi's Laboratories Limited	₹9,559	₹2.4L Cr	79.8	15.15	16.5	22	0.01
TORNTPHARM Torrent Pharmaceuticals Limited	₹4,557	₹1.7L Cr	79.3	9.43	27.4	15.2	0.77
ZYDUSLIFE Zydus Lifesciences Limited	₹1,176	₹1.1L Cr	23.1	4.37	21.2	21.1	0.38
APOLLOHOSP Apollo Hospitals Enterprise Limited	₹8,137	₹1.1L Cr	52.8	12.35	21.2	17.4	0.88
CIPLA Cipla Limited	₹1,366	₹1.1L Cr	30.2	3.21	11.6	15.5	0.01
LAURUSLABS Laurus Labs Limited	₹2,182	₹1.1L Cr	97.4	22.22	18.3	17.8	0.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

LOTUSEYE · as of Mar 2026

Promoters40.22%0.08pp

DII0.04%

Public59.73%0.09pp

Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	56.58%	41.40%	40.24%	40.03%	40.14%	40.22%
DII	—	—	—	—	0.04%	0.04%
Public	43.42%	58.60%	59.76%	59.97%	59.82%	59.73%

Corporate Events

Dividend - Re 0.50 Per Share

Dividend17 Sept 2023

Annual General Meeting

AGM17 Sept 2023

Latest News

All news

Lotus Eye Hospital to hold AGM on Sep 23, 2026

*Lotus Eye Hospital to hold AGM on Sep 23, 2026.* The company has announced its 29th Annual General Meeting scheduled for September 23, 2026. This is a routine corporate event with no immediate financial impact. Shareholders will review annual performance and discuss governance matters. 📊 *STOCKS:* LOTUSEYE | 🏢 *SECTOR:* Healthcare | #Corporate #AGM

NSE Filing1 Sept

Low Impact

Lotus Eye launches 'Lotus Optique' optical store

*Lotus Eye launches 'Lotus Optique' optical store.* The company announced the launch of its new retail optical venture on August 27, 2026, aiming to expand its footprint in eye care services. The move marks a strategic diversification into the optical retail segment. No financial details or revenue impact were disclosed. 📊 *STOCKS:* $LOTUSEYE | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #OpticalRetail

NSE Filing27 Aug

Low Impact

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is Lotus Eye Hospital and Institute Limited share price today?

Lotus Eye Hospital and Institute Limited (LOTUSEYE) is currently trading at ₹109.54 on NSE, down 0.10% as of the last market session. Prices update daily after market close on MarketNetra.

Is Lotus Eye Hospital and Institute Limited available in F&O (Futures & Options)?

Yes, Lotus Eye Hospital and Institute Limited (LOTUSEYE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.

What is Lotus Eye Hospital and Institute Limited 52-week high and low?

Lotus Eye Hospital and Institute Limited's 52-week high is ₹147 and the 52-week low is ₹67.72. The current price of ₹109.54 is 25.5% below the 52W high.

What is Lotus Eye Hospital and Institute Limited P/E ratio?

Lotus Eye Hospital and Institute Limited's current P/E ratio is 2,709.25. This indicates the market is paying ₹2,709.25 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.

How to trade Lotus Eye Hospital and Institute Limited options?

Lotus Eye Hospital and Institute Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade LOTUSEYE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.